The EORTC Genito-Urinary Tract Cancer Group: 25 Years of achievements and future strategies

European Journal of Cancer

Volumn 38, Issue SUPPL. 4, 2002, Pages 71-74

  Bono, A ^a   Zurlo, A ^b  

^a OSPEDALE DI CIRCOLO   (Italy)

^b EORTC DATA CENTER   (Belgium)

Author keywords

Bladder cancer; Genito urinary tumours; Germ cell cancer; Kidney cancer; Prostate cancer; Quality of life; Randomised trials

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; EPIRUBICIN; IFOSFAMIDE; INTERFERON; PACLITAXEL; VINCRISTINE;

ARTICLE; BLADDER CARCINOMA; CANCER RESEARCH; CLINICAL PRACTICE; CLINICAL TRIAL; HEALTH CARE ORGANIZATION; HUMAN; INTERNATIONAL COOPERATION; KIDNEY CARCINOMA; PENIS CARCINOMA; PRIORITY JOURNAL; PROSTATE CARCINOMA; QUALITY CONTROL; QUALITY OF LIFE; TESTIS CARCINOMA; UROGENITAL TRACT CANCER;

EID: 0036175210     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0959-8049(01)00463-4     Document Type: Article

References (13)

1. The European Organisation for Research and Treatment of Cancer approach to developing questionnaire modules: An update and overview
2. European Organisation for Research and Treatment of Cancer (EORTC) prostate cancer trials, 1976-1996
3. The importance of prognostic factors in the interpretation of two EORTC metastatic prostate cancer trials
4. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin
5. Baseline quality of life of patients with advanced prostate cancer
6. Multicenter trials in the prophylactic treatment of stage Ta T1 bladder cancer: The EORTC experience
7. A combined analysis of European Organisation for Research and Treatment of Cancer, and Medical Research Council randomized clinical trials for the prophylactic treatment of stage TaT1 bladder cancer
8. Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: A randomised controlled trial
9. Radical nephrectomy with and without lymph node dissection: Preliminary results of the EORTC randomized phase III protocol 30881
10. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: A randomised trial
11. Treatment of disseminated non-seminomatous testicular cancer: The European experience
12. Management of intermediate-prognosis germ-cell cancer: Results of a phase I/II study of Taxol-BEP
13. Health-related quality of life in patients treated for testicular cancer